Chadebech Philippe, de Ménorval Marie-Amélie, Bodivit Gwellaouen, Mekontso-Dessap Armand, Pakdaman Sadaf, Jouard Alicia, Galactéros Frédéric, Bierling Philippe, Habibi Anoosha, Pirenne France
Etablissement Français du Sang, Île-de-France, Hôpital Henri-Mondor.
IMRB-INSERM U955, Equipe 2-Transfusion et Maladies du Globule Rouge, Institut Mondor, Créteil, France.
Transfusion. 2016 Jul;56(7):1730-8. doi: 10.1111/trf.13636. Epub 2016 May 17.
The transfusion of red blood cell (RBC) concentrates is the main treatment for acute vaso-occlusive symptoms in sickle cell disease (SCD). Units of packed RBCs (pRBCs) must retain optimal characteristics for transfusion throughout the storage period. Transfused RBCs interact with the plasma and the endothelium that lines blood vessels and may be the target of immune-hematologic conflict if the patient produces antibodies against RBCs. Questions remain concerning the benefit-risk balance of RBC transfusions, in particular about the shelf-life of the units.
Plasma samples from 33 hemoglobin SS patients with SCD who had severe acute-phase symptoms or were in steady-state were put in contact with 10 fresh-stored and older stored samples from the same 10 RBC units. The factors affecting RBC survival (phosphatidylserine exposure, cytosolic calcium influx, cell size reduction) were analyzed.
We show that the effects of plasma samples from patients with SCD on pRBCs depend on the clinical condition of the patients and the duration of red cell storage. Signs of RBC senescence were correlated with the clinical status of the patient from whom the plasma sample was obtained. A decrease in RBC size and an increase in phosphatidylserine exposure were correlated with the duration of RBC storage. The behavior of cryopreserved pRBCs was similar to that of fresh refrigerated RBCs when challenged with patient plasma samples.
The key points of this study are that the clinical condition of patients with SCD can negatively affect the integrity of pRBCs for transfusion, and those effects increase with longer storage. Also, cryopreserved pRBCs behave similarly to fresh RBCs when challenged with plasma samples from patients with SCD in acute phase. Our data provide the first evidence that fresh RBCs stored for short periods may be of greater benefit to patients with SCD than RBCs that have been refrigerated for longer periods, particularly for those who have acute symptoms of SCD.
红细胞浓缩液输注是镰状细胞病(SCD)急性血管阻塞症状的主要治疗方法。浓缩红细胞(pRBCs)单位必须在整个储存期保持最佳的输血特性。输注的红细胞与血浆和血管内皮相互作用,如果患者产生针对红细胞的抗体,可能成为免疫血液学冲突的靶点。关于红细胞输血的利弊平衡,尤其是单位的保质期,仍存在疑问。
从33例患有严重急性期症状或处于稳定期的镰状细胞病血红蛋白SS患者中采集血浆样本,使其与来自相同10个红细胞单位的10个新鲜储存和陈旧储存样本接触。分析影响红细胞存活的因素(磷脂酰丝氨酸暴露、胞质钙内流、细胞大小减小)。
我们发现,SCD患者的血浆样本对pRBCs的影响取决于患者的临床状况和红细胞储存时间。红细胞衰老迹象与采集血浆样本的患者的临床状态相关。红细胞大小减小和磷脂酰丝氨酸暴露增加与红细胞储存时间相关。当用患者血浆样本进行挑战时,冷冻保存的pRBCs的行为与新鲜冷藏的红细胞相似。
本研究的关键点在于,SCD患者的临床状况会对用于输血的pRBCs的完整性产生负面影响,且这些影响会随着储存时间的延长而增加。此外,当用急性期SCD患者的血浆样本进行挑战时,冷冻保存的pRBCs的行为与新鲜红细胞相似。我们的数据首次证明,短期储存的新鲜红细胞可能比长期冷藏的红细胞对SCD患者更有益,特别是对于那些有SCD急性症状的患者。